Liver’s defense mechanism hinders immunity in chronic hepatitis B, study reveals

FHS
July 11, 2024
6:45 am

In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells blood vessels in the liver start a “sleep timer” that switches off immune cells. Targeting this mechanism could be a starting point for immunotherapies.

Big Blow to Anticoagulation Strategy Against Afib-Related Cognition Problems

CHICAGO — Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the route of anticoagulation to mitigate subclinical brain

November 18, 2024

Future of EMRs: AI-Powered, Patient-Centric, and Interoperable

Mallika Edwards, Chief Product Officer, Xsolis Imagine a world where a patient can visit any healthcare provider around the globe, and that provider has access

October 24, 2024

How to take advantage of the connected health opportunity in your next drug launch – Pharmaceutical Technology

For a pharmaceutical company that has just navigated a complicated market access journey preceded by ten-plus years of drug development, it’s a big moment when

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.